{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:36:19Z","timestamp":1753889779589,"version":"3.41.2"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["IDDT"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Recently, the emergence and spread of extended-spectrum beta-lactamase\n(ESBL) bacteria have become a global health concern. In addition, the ability to form biofilm due to\nless impermeability to antibiotics and the horizontal transformation (conjugation) of genes involved in\nantibiotic resistance have exacerbated the concerns. With a comprehensive meta-analysis, this study\nevaluated the potential relationship between ESBL and biofilm formation<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A literature search was performed using global databases, such as PubMed and Scopus, up to\nNovember 2021. We retrieved all relevant documents and selected eligible articles based on inclusion\ncriteria. Finally, the potential association between the biofilm formation capacity and resistance of\nESBL-producing bacteria was measured with an odds ratio and a 95% confidence interval.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>In the present study, 17 articles, including 2,069 Gram-negative isolates, were considered as\neligible. The prevalence of biofilm formation in all clinical isolates of ESBL and non-ESBL pathogens\nwas 72.4% (95% CI: 60.7-81.6) and 40.5% (95% CI: 30.2-51.8), respectively. Our results showed a\npositive relationship between the ability for biofilm formation and conferring antibiotic resistance in\nESBL-producing bacteria (OR: 3.35; 95% CI: 1.67-6.74; p-value: 0.001).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>In general, we showed the rate of biofilm formation to be significantly higher in ESBLproducing strains. Given the current results, the updated therapeutic guidelines should consider the role\nof biofilm production for optimal therapy, treatment course, and clinical outcomes rather than the recommendation of antimicrobial agents by focusing on the results of the antibiotic susceptibility test.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871526522666220920141631","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T15:35:19Z","timestamp":1663688119000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biofilm Formation Status in ESBL-Producing Bacteria Recovered from\nClinical Specimens of Patients: A Systematic Review and Meta-Analysis"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1208-8479","authenticated-orcid":true,"given":"Mohsen","family":"Karbalaei","sequence":"first","affiliation":[{"name":"Department of Microbiology\nand Virology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9899-2885","authenticated-orcid":true,"given":"Masoud","family":"Keikha","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Virology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad,\nIran"},{"name":"Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S1473-3099(20)30003-7","volume":"20","author":"Laxminarayan R.","year":"2020","unstructured":"Laxminarayan R.; Van Boeckel T.; Frost I.; The lancet infectious diseases commission on antimicrobial resistance: 6 years later. Lancet Infect Dis 2020,20(4),e51-e60","journal-title":"Lancet Infect Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1056\/NEJMra0904124","volume":"362","author":"Peleg A.Y.","year":"2010","unstructured":"Peleg A.Y.; Hooper D.C.; Hospital-acquired infections due to gram-negative bacteria. N Engl J Med 2010,362(19),1804-1813","journal-title":"N Engl J Med"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0255-0857(21)02884-X","volume":"22","author":"Chaudhary U.","year":"2004","unstructured":"Chaudhary U.; Aggarwal R.; Extended spectrum &#x3B2;-lactamases (ESBL) \u2013 An emerging threat to clinical therapeutics. Indian J Med Microbiol 2004,22(2),75-80","journal-title":"Indian J Med Microbiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","volume":"9","author":"Nordmann P.","year":"2009","unstructured":"Nordmann P.; Cuzon G.; Naas T.; The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009,9(4),228-236","journal-title":"Lancet Infect Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1128\/CMR.00001-07","volume":"20","author":"Queenan A.M.","year":"2007","unstructured":"Queenan A.M.; Bush K.; Carbapenemases: The versatile &#x3B2;-lactamases. Clin Microbiol Rev 2007,20(3),440-458","journal-title":"Clin Microbiol Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","volume":"10","author":"Kumarasamy K.K.","year":"2010","unstructured":"Kumarasamy K.K.; Toleman M.A.; Walsh T.R.; Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study. Lancet Infect Dis 2010,10(9),597-602","journal-title":"Lancet Infect Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1473-3099(04)01094-1","volume":"4","author":"Carmichael G.","year":"2004","unstructured":"Carmichael G.; ESBLs: the next challenge in infection control. Lancet Infect Dis 2004,4(8),480","journal-title":"Lancet Infect Dis"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jcma.2017.07.012","volume":"81","author":"Jamal M.","year":"2018","unstructured":"Jamal M.; Ahmad W.; Andleeb S.; Bacterial biofilm and associated infections. J Chin Med Assoc 2018,81(1),7-11","journal-title":"J Chin Med Assoc"},{"key":"ref=9","first-page":"745","volume":"29","author":"Rahdar H.A.","year":"2019","unstructured":"Rahdar H.A.; Malekabad E.S.; Dadashi A-R.; Correlation between biofilm formation and carbapenem resistance among clinical isolates of Klebsiella pneumoniae. Ethiop J Health Sci 2019,29(6),745-750","journal-title":"Ethiop J Health Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/scientificamerican0178-86","volume":"238","author":"Costerton J.W.","year":"1978","unstructured":"Costerton J.W.; Geesey G.G.; Cheng K.J.; How bacteria stick. Sci Am 1978,238(1),86-95","journal-title":"Sci Am"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1078\/1438-4221-00196","volume":"292","author":"Stewart P.S.","year":"2002","unstructured":"Stewart P.S.; Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol 2002,292(2),107-113","journal-title":"Int J Med Microbiol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.tim.2014.02.001","volume":"22","author":"Van Acker H.","year":"2014","unstructured":"Van Acker H.; Van Dijck P.; Coenye T.; Molecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilms. Trends Microbiol 2014,22(6),326-333","journal-title":"Trends Microbiol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.lwt.2009.12.008","volume":"43","author":"Sim&#xF5;es M.","year":"2010","unstructured":"Sim&#xF5;es M.; Sim&#xF5;es L.C.; Vieira M.J.; A review of current and emergent biofilm control strategies. Lebensm Wiss Technol 2010,43(4),573-583","journal-title":"Lebensm Wiss Technol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1574-6941.2003.tb01073.x","volume":"43","author":"Schwartz T.","year":"2003","unstructured":"Schwartz T.; Kohnen W.; Jansen B.; Obst U.; Detection of antibiotic-resistant bacteria and their resistance genes in wastewater, surface water, and drinking water biofilms. FEMS Microbiol Ecol 2003,43(3),325-335","journal-title":"FEMS Microbiol Ecol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijantimicag.2009.12.011","volume":"35","author":"H&#xF8;iby N.","year":"2010","unstructured":"H&#xF8;iby N.; Bjarnsholt T.; Givskov M.; Molin S.; Ciofu O.; Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents 2010,35(4),322-332","journal-title":"Int J Antimicrob Agents"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1413-8670(11)70197-0","volume":"15","author":"Hassan A.","year":"2011","unstructured":"Hassan A.; Usman J.; Kaleem F.; Omair M.; Khalid A.; Iqbal M.; Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis 2011,15(4),305-311","journal-title":"Braz J Infect Dis"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1046\/j.1365-2958.2002.02827.x","volume":"43","author":"G&#xF6;tz F.","year":"2002","unstructured":"G&#xF6;tz F.; Staphylococcus and biofilms. Mol Microbiol 2002,43(6),1367-1378","journal-title":"Mol Microbiol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2217\/fmb.10.125","volume":"5","author":"H&#xF8;iby N.","year":"2010","unstructured":"H&#xF8;iby N.; Ciofu O.; Bjarnsholt T.; Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 2010,5(11),1663-1674","journal-title":"Future Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1093\/jac\/dks429","volume":"68","author":"Nicolas-Chanoine M.H.","year":"2013","unstructured":"Nicolas-Chanoine M.H.; Gruson C.; Bialek-Davenet S.; 10-Fold increase (2006-11) in the rate of healthy subjects with extended-spectrum -lactamase-producing Escherichia coli faecal carriage in a Parisian check-up centre. J Antimicrob Chemother 2013,68(3),562-568","journal-title":"J Antimicrob Chemother"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1128\/AAC.00475-12","volume":"56","author":"Novais &#xC2;.","year":"2012","unstructured":"Novais &#xC2;.; Pires J.; Ferreira H.; Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010). Antimicrob Agents Chemother 2012,56(7),3973-3976","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1128\/MMBR.00013-14","volume":"78","author":"Lebeaux D.","year":"2014","unstructured":"Lebeaux D.; Ghigo J.M.; Beloin C.; Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recal-citrance toward antibiotics. Microbiol Mol Biol Rev 2014,78(3),510-543","journal-title":"Microbiol Mol Biol Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"824","DOI":"10.3389\/fchem.2019.00824","volume":"7","author":"Verderosa A.D.","year":"2019","unstructured":"Verderosa A.D.; Totsika M.; Fairfull-Smith K.E.; Bacterial biofilm eradication agents: A current review. Front Chem 2019,7,824","journal-title":"Front Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"Stepanovi\u0107 S.","year":"2007","unstructured":"Stepanovi\u0107 S.; Vukovi\u0107 D.; Hola V.; Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recom-mendations for assessment of biofilm production by Staphylococci. Acta Pathol Microbiol Scand Suppl 2007,115(8),891-899","journal-title":"Acta Pathol Microbiol Scand Suppl"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jhin.2008.02.001","volume":"68","author":"Yang D.","year":"2008","unstructured":"Yang D.; Zhang Z.; Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum &#x3B2;-lactamases. J Hosp Infect 2008,68(4),369-371","journal-title":"J Hosp Infect"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"e15514","DOI":"10.5812\/jjm.15514","volume":"8","author":"Heydari S.","year":"2015","unstructured":"Heydari S.; Eftekhar F.; Biofilm formation and &#x3B2;-lactamase production in burn isolates of Pseudomonas aeruginosa. Jundishapur J Microbiol 2015,8(3),e15514","journal-title":"Jundishapur J Microbiol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1179\/2047773215Y.0000000001","volume":"109","author":"Mittal S.","year":"2015","unstructured":"Mittal S.; Sharma M.; Chaudhary U.; Biofilm and multidrug resistance in uropathogenic Escherichia coli. Pathog Glob Health 2015,109(1),26-29","journal-title":"Pathog Glob Health"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13756-016-0104-9","volume":"5","author":"Neupane S.","year":"2016","unstructured":"Neupane S.; Pant N.D.; Khatiwada S.; Chaudhary R.; Banjara M.R.; Correlation between biofilm formation and resistance toward different commonly used antibiotics along with extended spectrum beta lactamase production in uropathogenic Escherichia coli isolated from the patients suspected of urinary tract infections visiting Shree Birendra Hospital, Chhauni, Kathmandu, Nepal. Antimicrob Resist Infect Control 2016,5(1),5","journal-title":"Antimicrob Resist Infect Control"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"7279830","DOI":"10.1155\/2017\/7279830","volume":"2017","author":"Gharrah M.M.","year":"2017","unstructured":"Gharrah M.M.; Mostafa El-Mahdy A.; Barwa R.F.; Association between virulence factors and extended spectrum beta-lactamase producing Klebsiella pneumoniae compared to nonproducing isolates. Interdiscip Perspect Infect Dis 2017,2017,7279830","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ijms18051077","volume":"18","author":"Di Domenico E.","year":"2017","unstructured":"Di Domenico E.; Farulla I.; Prignano G.; Biofilm is a major virulence determinant in bacterial colonization of chronic skin ulcers independently from the multidrug resistant phenotype. Int J Mol Sci 2017,18(5),1077","journal-title":"Int J Mol Sci"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5604\/01.3001.0010.7042","volume":"66","author":"Shah R.K.","year":"2017","unstructured":"Shah R.K.; Ni Z.H.; Sun X.; Wang G.Q.; Li F.; The determination and correlation of various virulence genes, ESBL, serum bactericidal effect and biofilm formation of clinical isolated classical Klebsiella pneumoniae and hypervirulent Klebsiella pneumoniae from respiratory tract infected patients. Pol J Microbiol 2017,66(4),501-508","journal-title":"Pol J Microbiol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.12980\/apjtd.7.2017D7-15","volume":"7","author":"Nepal H.P.","year":"2017","unstructured":"Nepal H.P.; Neopane P.; Shrestha R.; Biofilm formation and antimicrobial resistance in Klebsiella pneumoniae isolated from patients visiting a tertiary care center of Nepal. Asian Pac J Trop Dis 2017,7(6),347-351","journal-title":"Asian Pac J Trop Dis"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jgar.2018.03.006","volume":"14","author":"Shahbazi S.","year":"2018","unstructured":"Shahbazi S.; Asadi Karam M.R.; Habibi M.; Talebi A.; Bouzari S.; Distribution of extended-spectrum &#x3B2;-lactam, quinolone and carbapenem resistance genes, and genetic diversity among uropathogenic Escherichia coli isolates in Tehran, Iran. J Glob Antimicrob Resist 2018,14,118-125","journal-title":"J Glob Antimicrob Resist"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3855\/jidc.9677","volume":"12","author":"Yazgan B.","year":"2018","unstructured":"Yazgan B.; T&#xFC;rkel I.; G&#xFC;&#xE7;kan R.; K\u0131l\u0131n&#xE7; K.; Y\u0131ld\u0131r\u0131m T.; Comparison of biofilm formation and efflux pumps in ESBL and carbapenemase producing Klebsiella pneumoniae. J Infect Dev Ctries 2018,12(3),156-163","journal-title":"J Infect Dev Ctries"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jgar.2018.01.018","volume":"13","author":"Asadpour L.","year":"2018","unstructured":"Asadpour L.; Antimicrobial resistance, biofilm-forming ability and virulence potential of Pseudomonas aeruginosa isolated from burn patients in northern Iran. J Glob Antimicrob Resist 2018,13,214-220","journal-title":"J Glob Antimicrob Resist"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12941-019-0340-y","volume":"18","author":"Shrestha R.","year":"2019","unstructured":"Shrestha R.; Khanal S.; Poudel P.; Extended spectrum &#x3B2;-lactamase producing uropathogenic Escherichia coli and the correlation of bio-film with antibiotics resistance in Nepal. Ann Clin Microbiol Antimicrob 2019,18(1),42","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2147\/IDR.S192072","volume":"12","author":"Zhang Q.","year":"2019","unstructured":"Zhang Q.; Gao H.Y.; Li D.; Clinical outcome of Escherichia coli bloodstream infection in cancer patients with\/without biofilm formation: A single-center retrospective study. Infect Drug Resist 2019,12,359-371","journal-title":"Infect Drug Resist"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.11604\/pamj.2020.36.233.21815","volume":"36","author":"Shahbazzadeh M.","year":"2020","unstructured":"Shahbazzadeh M.; Moazamian E.; Rafati A.; Fardin M.; Antimicrobial resistance pattern, genetic distribution of ESBL genes, biofilm-forming potential, and virulence potential of Pseudomonas aeruginosa isolated from the burn patients in Tehran Hospitals, Iran. Pan Afr Med J 2020,36,233","journal-title":"Pan Afr Med J"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/diseases8020017","volume":"8","author":"Behzadi P.","year":"2020","unstructured":"Behzadi P.; Urb&#xE1;n E.; Gajd&#xE1;cs M.; Association between biofilm-production and antibiotic resistance in uropathogenic Escherichia coli (UPEC): An in vitro study. Diseases 2020,8(2),17","journal-title":"Diseases"},{"key":"ref=39","author":"Sa\u2019id A.S.","year":"2020","unstructured":"Sa\u2019id A.S.; Mukhkar M.; Bukar A.; Yusha\u2019u M.;  Extended spectrum beta-lactamase production, biofilm formation and antibiotic resistance in clinical isolates of Klebsiella pneumoniae 2020","journal-title":"Extended spectrum beta-lactamase production, biofilm formation and antibiotic resistance in clinical isolates of Klebsiella pneumoniae"},{"key":"ref=40","first-page":"59","volume":"33","author":"Damiano P.","year":"2021","unstructured":"Damiano P.; Salema E.J.; Silago V.; The susceptibility of multidrug resistant and biofilm forming Klebsiella pneumoniae and Escherichia coli to antiseptic agents used for preoperative skin preparations at zonal referral hospital in Mwanza, Tanzania. Malawi Med J 2021,33(1),59-64","journal-title":"Malawi Med J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijmm.2018.10.008","volume":"309","author":"Surgers L.","year":"2019","unstructured":"Surgers L.; Boyd A.; Girard P.M.; Arlet G.; Decr&#xE9; D.; Biofilm formation by ESBL-producing strains of Escherichia coli and Klebsiella pneu-moniae. Int J Med Microbiol 2019,309(1),13-18","journal-title":"Int J Med Microbiol"},{"key":"ref=42","first-page":"1143","volume":"4","author":"Norouzi F.","year":"2010","unstructured":"Norouzi F.; Mansouri S.; Moradi M.; Razavi M.; Comparison of cell surface hydrophobicity and biofilm formation among ESBL-and nonESBL-producing Pseudomonas aeruginosa clinical isolates. Afr J Microbiol Res 2010,4(11),1143-1147","journal-title":"Afr J Microbiol Res"},{"key":"ref=43","first-page":"60","volume":"1","author":"Tadepalli S.","year":"2016","unstructured":"Tadepalli S.; Prudhivi S.; Babu Myneni R.; Rao S.; Biofilm formation in uropathogenic Escherichia coli isolates and its association with extended spectrum betalactamase production and drug resistance. Saudi J Pathol Microbiol 2016,1(2),60-64","journal-title":"Saudi J Pathol Microbiol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1086\/649021","volume":"31","author":"Lautenbach E.","year":"2010","unstructured":"Lautenbach E.; Synnestvedt M.; Weiner M.G.; Imipenem resistance in Pseudomonas aeruginosa: Emergence, epidemiology, and impact on clinical and economic outcomes. Infect Control Hosp Epidemiol 2010,31(1),47-53","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1128\/JCM.43.7.3110-3113.2005","volume":"43","author":"Black J.A.","year":"2005","unstructured":"Black J.A.; Moland E.S.; Thomson K.S.; AmpC disk test for detection of plasmid-mediated AmpC &#x3B2;-lactamases in Enterobacteriaceae lacking chromosomal AmpC &#x3B2;-lactamases. J Clin Microbiol 2005,43(7),3110-3113","journal-title":"J Clin Microbiol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"Paterson D.L.","year":"2005","unstructured":"Paterson D.L.; Bonomo R.A.; Extended-spectrum &#x3B2;-lactamases: A clinical update. Clin Microbiol Rev 2005,18(4),657-686","journal-title":"Clin Microbiol Rev"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/2249-5975.119797","volume":"2","author":"Subramanian P.","year":"2012","unstructured":"Subramanian P.; Umadevi S.; Kumar S.; Stephen S.; Determination of correlation between biofilm and extended spectrum &#x3B2; lactamases producers of Enterobacteriaceae. Scholars Res J 2012,2(1),2","journal-title":"Scholars Res J"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.micinf.2011.08.015","volume":"14","author":"Fuursted K.","year":"2012","unstructured":"Fuursted K.; Sch&#xF8;ler L.; Hansen F.; Virulence of a Klebsiella pneumoniae strain carrying the New Delhi metallo-beta-lactamase-1 (NDM-1). Microbes Infect 2012,14(2),155-158","journal-title":"Microbes Infect"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.4066\/AMJ.2012.1193","volume":"5","author":"Subramanian P.","year":"2012","unstructured":"Subramanian P.; Shanmugam N.; Sivaraman U.; Kumar S.; Selvaraj S.; Antiobiotic resistance pattern of biofilm forming uropathogens isolated from catheterised patients in Pondicherry, India. Australas Med J 2012,5(7),344-348","journal-title":"Australas Med J"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1574-6968.2004.tb09643.x","volume":"236","author":"Jefferson K.K.","year":"2004","unstructured":"Jefferson K.K.; What drives bacteria to produce a biofilm? FEMS Microbiol Lett 2004,236(2),163-173","journal-title":"FEMS Microbiol Lett"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1128\/AAC.00010-08","volume":"52","author":"Sahly H.","year":"2008","unstructured":"Sahly H.; Navon-Venezia S.; Roesler L.; Extended-spectrum &#x3B2;-lactamase production is associated with an increase in cell invasion and expression of fimbrial adhesins in Klebsiella pneumoniae. Antimicrob Agents Chemother 2008,52(9),3029-3034","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00134-002-1521-1","volume":"28","author":"Du B.","year":"2002","unstructured":"Du B.; Long Y.; Liu H.; Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: Risk factors and clinical outcome. Intensive Care Med 2002,28(12),1718-1723","journal-title":"Intensive Care Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/1040841X.2013.804031","volume":"41","author":"Juhas M.","year":"2015","unstructured":"Juhas M.; Horizontal gene transfer in human pathogens. Crit Rev Microbiol 2015,41(1),101-108","journal-title":"Crit Rev Microbiol"},{"key":"ref=54","first-page":"582","volume":"50","author":"Sahal G.","year":"2016","unstructured":"Sahal G.; Avcioglu N.H.; Bilkay I.S.; Higher biofilm formation by multidrug resistant K. pneumoniae and K. rhinoscleromatis strains and effects of lemon and ginger essential oils on biofilm formation. Indian J Pharma Edu Res 2016,50(2),582-588","journal-title":"Indian J Pharma Edu Res"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2334-13-47","volume":"13","author":"Sanchez C.J.","year":"2013","unstructured":"Sanchez C.J.; Mende K.; Beckius M.L.; Biofilm formation by clinical isolates and the implications in chronic infections. BMC Infect Dis 2013,13(1),47","journal-title":"BMC Infect Dis"},{"key":"ref=56","first-page":"47","volume":"28","author":"Hadadi-Fishani M.","year":"2020","unstructured":"Hadadi-Fishani M.; Khaledi A.; Fatemi-Nasab Z.S.; Correlation between biofilm formation and antibiotic resistance in Pseudomonas aeruginosa: A meta-analysis. Infez Med 2020,28(1),47-54","journal-title":"Infez Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00248-013-0361-6","volume":"68","author":"Musafer H.K.","year":"2014","unstructured":"Musafer H.K.; Kuchma S.L.; Naimie A.A.; Schwartzman J.D.; AL-Mathkhury HJF, O\u2019Toole GA. Investigating the link between imipenem resistance and biofilm formation by Pseudomonas aeruginosa. Microb Ecol 2014,68(1),111-120","journal-title":"Microb Ecol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1179\/1973947813Y.0000000159","volume":"27","author":"Perez L.R.R.","year":"2015","unstructured":"Perez L.R.R.; Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production. J Chemother 2015,27(1),13-16","journal-title":"J Chemother"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e30682","DOI":"10.5812\/jjm.30682","volume":"9","author":"Seifi K.","year":"2016","unstructured":"Seifi K.; Kazemian H.; Heidari H.; Evaluation of biofilm formation among Klebsiella pneumoniae isolates and molecular characterization by ERIC-PCR. Jundishapur J Microbiol 2016,9(1),e30682","journal-title":"Jundishapur J Microbiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"229","DOI":"10.7860\/JCDR\/2013\/4619.2734","volume":"7","author":"Kaur J.","year":"2013","unstructured":"Kaur J.; Chopra S.; Sheevani G.M.; Mahajan G.; Modified double disc synergy test to detect ESBL production in urinary isolates of Escherichia coli and Klebsiella pneumoniae. J Clin Diagn Res 2013,7(2),229-233","journal-title":"J Clin Diagn Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/pathogens3030743","volume":"3","author":"Vuotto C.","year":"2014","unstructured":"Vuotto C.; Longo F.; Balice M.; Donelli G.; Varaldo P.; Antibiotic resistance related to biofilm formation in Klebsiella pneumoniae. Pathogens 2014,3(3),743-758","journal-title":"Pathogens"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/543974","volume":"2014","author":"Soto S.M.","year":"2014","unstructured":"Soto S.M.; Importance of biofilms in urinary tract infections: New therapeutic approaches. Adv Biol 2014,2014,1-13","journal-title":"Adv Biol"}],"container-title":["Infectious Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220920141631","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208987\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871526522666220920141631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T04:18:10Z","timestamp":1679977090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208987\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871526522666220920141631","relation":{},"ISSN":["1871-5265"],"issn-type":[{"type":"print","value":"1871-5265"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-03","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e200922208987"}}